Cannabis has been used for menstrual pain management for millennia — Queen Victoria's physician prescribed cannabis tincture for dysmenorrhea in the 1800s. Yet rigorous clinical research on cannabis and women's reproductive health remains sparse compared to its use in pain and neurology. That is beginning to change.
Dysmenorrhea and Menstrual Pain
A 2019 survey study published in Journal of Women's Health found that 84% of women who used cannabis for menstrual pain reported it as effective or very effective, with 90% preferring it over NSAIDs for certain symptoms [1]. The endocannabinoid system has direct involvement in uterine function — CB1 receptors are expressed in human myometrium, and endocannabinoid levels fluctuate across the menstrual cycle.
The anti-inflammatory and muscle-relaxing properties of both THC and CBD make them mechanistically plausible candidates for dysmenorrhea. However, clinical trial data remains limited to observational studies. The evidence base here is stronger from patient-reported outcomes than from controlled trials.
Menopause Symptom Relief
A 2020 study from the North American Menopause Society found that 27% of menopausal women surveyed had used cannabis in the past year, primarily for sleep, anxiety, and joint pain — with 67% rating it effective [2]. Hot flashes, mood changes, and sleep disruption are the primary targets in clinical discussions.
The endocannabinoid system modulates hypothalamic thermoregulation, which controls hot flash physiology. This provides a mechanistic basis for cannabis use in menopause, but no RCT has specifically tested this application.
Key Evidence Points
- 84% of women using cannabis for menstrual pain rated it effective; 90% preferred it to NSAIDs for some symptoms [1]
- CB1 receptors expressed in human uterine myometrium — direct physiological relevance established
- 27% of menopausal women report recent cannabis use; 67% rate it effective for menopause symptoms [2]
- No large RCT has specifically studied cannabis for dysmenorrhea or menopause
- Cannabis use during pregnancy is associated with adverse fetal outcomes — not recommended
Critical Safety Note
Cannabis use during pregnancy is not supported by safety data and is associated with lower birth weight and preterm birth in observational research. Cannabis should not be used during pregnancy or breastfeeding. The research discussed here pertains to non-pregnant adults.